Aveanna Healthcare Holdings Inc. — Form 8-K Summary
Business context and reporting period
Aveanna Healthcare Holdings Inc. filed this Form 8-K on August 10, 2023, under Items 2.02, 7.01 and 9.01. The filing announces financial results for the three and six-month periods ended July 1, 2023. The company’s common stock trades on Nasdaq under the symbol AVAH.
Financial results and key metrics
The filing text identifies the release of financial results but does not include the underlying revenue, profitability, cash flow, margin, debt or liquidity figures. Those details are contained in Exhibit 99.1, which is referenced but not included in the provided text.
Material changes versus the prior comparable period
The provided filing text does not state the results for the prior comparable periods or describe year-over-year changes.
Guidance, outlook, risks and unusual items
The provided text does not include management guidance, outlook commentary, risk disclosures, contingencies or unusual items. It states that the information, including Exhibit 99.1, is furnished rather than filed for purposes of Section 18 of the Exchange Act.
Key facts for investors to verify
- Review Exhibit 99.1 for the actual three- and six-month financial results ended July 1, 2023.
- Verify reported revenue, net income or loss, adjusted measures, operating margins and cash flow.
- Review debt balances, liquidity, covenant compliance and any financing developments.
- Compare the reported results with the prior-year comparable periods and assess any changes in guidance or management outlook.
- Confirm that the financial information was furnished under Items 2.02 and 7.01 and was not filed for Section 18 liability purposes.